Literature DB >> 16377636

Formation of tau inclusions in knock-in mice with familial Alzheimer disease (FAD) mutation of presenilin 1 (PS1).

Kentaro Tanemura1, Du-Hua Chui, Tetsuya Fukuda, Miyuki Murayama, Jung-Mi Park, Takumi Akagi, Yoshitaka Tatebayashi, Tomohiro Miyasaka, Tetsuya Kimura, Tsutomu Hashikawa, Yuka Nakano, Takashi Kudo, Masatoshi Takeda, Akihiko Takashima.   

Abstract

Mutations in the presenilin 1 (PS1) gene are responsible for the early onset of familial Alzheimer disease (FAD). Accumulating evidence shows that PS1 is involved in gamma-secretase activity and that FAD-associated mutations of PS1 commonly accelerate Abeta(1-42) production, which causes Alzheimer disease (AD). Recent studies suggest, however, that PS1 is involved not only in Abeta production but also in other processes that lead to neurodegeneration. To better understand the causes of neurodegeneration linked to the PS1 mutation, we analyzed the development of tau pathology, another key feature of AD, in PS1 knock-in mice. Hippocampal samples taken from FAD mutant (I213T) PS1 knock-in mice contained hyperphosphorylated tau that reacted with various phosphodependent tau antibodies and with Alz50, which recognizes the conformational change of PHF tau. Some neurons exhibited Congo red birefringence and Thioflavin T reactivity, both of which are histological criteria for neurofibrillary tangles (NFTs). Biochemical analysis of the samples revealed SDS-insoluble tau, which under electron microscopy examination, resembled tau fibrils. These results indicate that our mutant PS1 knock-in mice exhibited NFT-like tau pathology in the absence of Abeta deposition, suggesting that PS1 mutations contribute to the onset of AD not only by enhancing Abeta(1-42) production but by also accelerating the formation and accumulation of filamentous tau.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377636     DOI: 10.1074/jbc.M509145200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Redox-based regulation of signal transduction: principles, pitfalls, and promises.

Authors:  Yvonne M W Janssen-Heininger; Brooke T Mossman; Nicholas H Heintz; Henry J Forman; Balaraman Kalyanaraman; Toren Finkel; Jonathan S Stamler; Sue Goo Rhee; Albert van der Vliet
Journal:  Free Radic Biol Med       Date:  2008-03-27       Impact factor: 7.376

3.  Presenilin-1 regulates the expression of p62 to govern p62-dependent tau degradation.

Authors:  Ying-Tsen Tung; Bo-Jeng Wang; Wen-Ming Hsu; Ming-Kuan Hu; Guor Mour Her; Wei-Pang Huang; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2013-06-23       Impact factor: 5.590

4.  Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model.

Authors:  Allal Boutajangout; David Quartermain; Einar M Sigurdsson
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

5.  Modeling presenilin-dependent familial Alzheimer's disease: emphasis on presenilin substrate-mediated signaling and synaptic function.

Authors:  Angèle T Parent; Gopal Thinakaran
Journal:  Int J Alzheimers Dis       Date:  2010-07-20

Review 6.  Presenilin transgenic mice as models of Alzheimer's disease.

Authors:  Gregory A Elder; Miguel A Gama Sosa; Rita De Gasperi; Dara L Dickstein; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2009-11-18       Impact factor: 3.270

7.  Hyperphosphorylation and accumulation of neurofilament proteins in transgenic mice with Alzheimer presenilin 1 mutation.

Authors:  Xifei Yang; Ying Yang; Yougen Luo; Geng Li; Jianzhi Wang; Edward S Yang
Journal:  Cell Mol Neurobiol       Date:  2009-01-10       Impact factor: 5.046

8.  Increased tauopathy drives microglia-mediated clearance of beta-amyloid.

Authors:  Wesley Chen; Edsel A Abud; Stephen T Yeung; Anita Lakatos; Trevor Nassi; Jane Wang; David Blum; Luc Buée; Wayne W Poon; Mathew Blurton-Jones
Journal:  Acta Neuropathol Commun       Date:  2016-06-23       Impact factor: 7.801

Review 9.  Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's Disease.

Authors:  Carol A Deaton; Gail V W Johnson
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

10.  The Neuroscience Research Institute at Peking University: a place for the solution of pain and drug abuse.

Authors:  Albert C H Yu; You Wan; De-Hua Chui; Cai-Lian Cui; Fei Luo; Ke-Wei Wang; Xiao-Min Wang; Yun Wang; Liu-Zhen Wu; Guo-Gang Xing; Ji-Sheng Han
Journal:  Cell Mol Neurobiol       Date:  2007-12-05       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.